ReviewFrontiers in immunology2021

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Zi-Yun Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.